Digital ECG data and AI will fuel pharma’s next drug development and... Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.
R&D Patterns of behaviour: Using AI-based algorithms to improve ... For those of us old enough to remember ringing in the year 2000, current concerns that artificial intelligence (AI) may usher in the end of the world as we know it may call to mind the fear
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.